Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.

Authors

Joseph M Caster
Artish N Patel
Tian Zhang
Andrew Wang

Publication/Presentation Date

1-1-2017

Abstract

Nanomedicine is a relatively new field that is rapidly evolving. Formulation of drugs on the nanoscale imparts many physical and biological advantages. Such advantages can in turn translate into improved therapeutic efficacy and reduced toxicity. While approximately 50 nanotherapeutics have already entered clinical practice, a greater number of drugs are undergoing clinical investigation for a variety of indications. This review aims to examine all the nanoformulations that are currently undergoing clinical investigation and their outlook for ultimate clinical translation. WIREs Nanomed Nanobiotechnol 2017, 9:e1416. doi: 10.1002/wnan.1416 For further resources related to this article, please visit the WIREs website.

Volume

9

Issue

1

ISSN

1939-0041

Published In/Presented At

Caster, J. M., Patel, A. N., Zhang, T., & Wang, A. (2017). Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 9(1), 10.1002/wnan.1416. https://doi.org/10.1002/wnan.1416

Disciplines

Medical Education | Medicine and Health Sciences

PubMedID

27312983

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article